In the News

For media inquiries: press@vibebio.com

As Seen

“Vibe is doing things a little differently. It operates as a DAO, or decentralized autonomous organization, run by people holding cryptocurrency tokens. Token holders can submit proposals for drug research projects, which will be vetted by a group of experts. Ultimately, the decision on which projects to fund will be made by a simple majority-rules vote among all of the token holders.”

read more

“Although rare diseases impact so many, capacity-constrained biotech and pharma companies have to prioritize which diseases to tackle. Vibe Bio is uniquely solving this problem through cryptocurrency tokens. Through its token, Vibe is able to raise funds and empower patients and scientists to direct those resources to the highest potential drug programs.”

read more

“Vibe Bio wants to change the incentive structure by attracting patients and families directly affected by rare diseases into the [...] research process. For Tayi, it’s a deeply personal mission. He spent 16 years as a lab researcher before becoming a biotech entrepreneur. And he has all-too direct experience with rare diseases.”

read more

“There actually ends up being a myriad of different candidate medicines with promise that are sitting on shelves today, but simply lack the capital and the focus to be able to develop them.”

read more

“Through his own personal and professional experience, Alok has realized that the families of patients with rare diseases have plenty of hope - but what they need is help. Not necessarily finding the right potential therapeutic option - but actually funding it. That’s where the Vibe community steps in - vetting out which drug development programs have the highest potential. ”

read more
READ MORE

“The company [Vibe Bio] has launched two biotech companies in partnership with two foundations: Chelsea’s Hope, which is focused on Lafora disease, a fatal form of progressive myoclonus epilepsy, and NF2 BioSolutions, which hopes to accelerate a gene therapy for neurofibromatosis Type 2, which causes the growth of noncancerous tumors in the nervous system.”

read more

“Vibe Bio is leveraging crypto's economic and coordination tools to fund the research and development that the legacy biotech industry ignores.”

read more
READ MORE

“Alok Tayi is the founder and CEO of Vibe Bio. Vibe Bio is a community of patients, scientists, and partners committed to identifying, funding and developing promising treatments to rare diseases and empowering patient communities with unprecedented ownership over the process.”

read more

“Tayi started Vibe Bio to transform drug development for patients wirh rare diseases, with part financing, part online coordination hub. [...] for example there is a patient advocacy organization dedicated to curing something called Lafora disease, which is a fatal form of progresive epilepsy, Vibe Bio is helping them launch New Hope Therapeutics.”

read more

Load More +